Literature DB >> 18078755

Adult medulloblastoma: clinical profile and treatment results of 18 patients.

Girish Menon1, K Krishnakumar, S Nair.   

Abstract

The objective of this article is to examine the clinicoradiological features and surgical outcomes of adult patients (>16 years) with medulloblastoma. An attempt was made to identify the predictors of poor outcome and assess patterns of relapse and to compare these with pediatric medulloblastoma. Retrospective case record analyses were performed on 18 adults (>16 years) and 79 children (<16 years) operated upon after January 1990, who had at least 5 years of follow-up. The following variables were assessed by bivariate analyses: age, location of the lesion, brainstem invasion, extent of excision and histological subtype. Statistical analysis was performed using chi-square test, Fischer's exact test and Student's t-test. Results revealed there was no gender preference. The tumor was located in the vermis in 12 patients (66.6%) and in the cerebellar hemisphere in six (16.6%). Calcification was observed in two cases (11.1%) and hydrocephalus was seen in six (33.3%). MRI evidence of brainstem infiltration was seen in three patients (16.6%). Total excision was achieved in 13 cases (72.2%), near total excision in four (22.2%) and subtotal excision in one. Major complications included fresh cranial nerve deficits in four patients (22.2%), hemiparesis and gait unsteadiness in three (16.6%), mutism in one and meningitis in two. All patients underwent adjuvant radiotherapy in the form of craniospinal irradiation with a posterior fossa boost. On follow-up, 11 patients (61.1%) were observed to have recurrence and all were located in the posterior fossa. All 11 subsequently underwent chemotherapy. Two patients had re-operation for residual/recurrent lesions causing raised intracranial symptoms. Five-year follow-up data showed that 10 patients (55.5%) were alive, five (27.7%) had died while three (16.6%) were lost to follow-up. In spite of recent advances in management, patients with medulloblastoma still have a poor prognosis. However, adults fared better than children. Vermian location had a better outcome in adults, but not in children. Desmoplastic variant histology was not observed to be a significant prognostic factor in the adult group while brain stem invasion carried a poor prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 18078755     DOI: 10.1016/j.jocn.2007.06.007

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  19 in total

1.  Magnetic resonance imaging spectrum of medulloblastoma.

Authors:  Julia Fruehwald-Pallamar; Stefan B Puchner; Andrea Rossi; Maria L Garre; Armando Cama; Claus Koelblinger; Anne G Osborn; Majda M Thurnher
Journal:  Neuroradiology       Date:  2011-01-29       Impact factor: 2.804

2.  Neuroradiology and histopathology in two cases of adult medulloblastoma.

Authors:  Alfredo E Romero-Rojas; Julio A Diaz-Perez; Sharat Raju; Alfonso Lozano-Castillo
Journal:  Neuroradiol J       Date:  2014-04-18

3.  Chemotherapy increases long-term survival in patients with adult medulloblastoma--a literature-based meta-analysis.

Authors:  Selin Kocakaya; Christoph Patrick Beier; Dagmar Beier
Journal:  Neuro Oncol       Date:  2015-09-10       Impact factor: 12.300

4.  Adult medulloblastoma: clinical characters, prognostic factors, outcomes and patterns of relapse.

Authors:  Na Zhang; Taohui Ouyang; Huicong Kang; Wang Long; Benjamin Thomas; Suiqiang Zhu
Journal:  J Neurooncol       Date:  2015-05-31       Impact factor: 4.130

5.  Medulloblastoma in adults. Treatment outcome, relapse patterns, and prognostic factors.

Authors:  S-F Lai; C-W Wang; Y-H Chen; K-H Lan; J C-H Cheng; A-L Cheng; S-H Kuo
Journal:  Strahlenther Onkol       Date:  2012-08-23       Impact factor: 3.621

6.  Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.

Authors:  Jason A Call; Mihir Naik; Fausto J Rodriguez; Caterina Giannini; Wenting Wu; Jan C Buckner; Ian F Parney; Nadia N Laack
Journal:  Am J Clin Oncol       Date:  2014-02       Impact factor: 2.339

7.  Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.

Authors:  Brian De; Kathryn Beal; Kevin C De Braganca; Mark M Souweidane; Ira J Dunkel; Yasmin Khakoo; Stephen W Gilheeney; Lisa M DeAngelis; Paul Menzel; Suchit H Patel; Suzanne L Wolden
Journal:  J Neurooncol       Date:  2017-10-10       Impact factor: 4.130

8.  MRI surrogates for molecular subgroups of medulloblastoma.

Authors:  S Perreault; V Ramaswamy; A S Achrol; K Chao; T T Liu; D Shih; M Remke; S Schubert; E Bouffet; P G Fisher; S Partap; H Vogel; M D Taylor; Y J Cho; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

9.  Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review.

Authors:  Eshagh Bahrami; Sahar Bakhti; Seyed-Mohammad Fereshtehnejad; Mansour Parvaresh; Mohammad Reza Khani
Journal:  Med J Islam Repub Iran       Date:  2014-07-13

10.  Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.

Authors:  Zhen-Yu Zhang; Jian Xu; Yong Ren; Kay Ka-Wai Li; Ho-Keung Ng; Ying Mao; Ping Zhong; Yu Yao; Liang-Fu Zhou
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.